Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169065
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2005-09-10
Brief Title:
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
Sponsor:
Harvard Medical School HMS and HSDM
Organization:
Harvard Medical School HMS and HSDM
Organization Data
Organization:
Harvard Medical School HMS and HSDM
Class:
OTHER
Study ID:
R01MH049891
Study Type:
NIH
Study Domain:
None
Study Link:
httpsreporternihgovquickSearchR01MH049891
Lead Sponsor:
Harvard Medical School HMS and HSDM
Lead Sponsor Class:
OTHER
Responsible Party:
AlanGreen
Responsible Party Title:
Chair Department of Psychiatry Geisel School of Medicine at Dartmouth
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Institute of Mental Health NIMH
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| National Institute of Mental Health NIMH | NIH |
| Dartmouth-Hitchcock Medical Center | OTHER |
| Commonwealth Research Center Massachusetts | OTHER |